Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/11/2003US6531307 Capable of activating a compound with little or no toxicity into an active product; use in treating viral diseases, cancer, and genetic disorders
03/11/2003US6531303 Method of producing geranylgeraniol
03/11/2003US6531297 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
03/11/2003US6531288 Methods to identify compounds that affect the expression level of the syntaxin-1 A encoding gene
03/11/2003US6531285 Automated detection apparatus with a conveying means for test columns
03/11/2003US6531279 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
03/11/2003US6531137 Retrovirus from the HIV group and its use
03/11/2003US6531135 Administering to the subject an effective amount of a composition comprising a population of infectious, defective alphavirus particles in a pharmaceutically acceptable carrier
03/11/2003US6531134 Mammalian milk growth factor
03/11/2003CA2109085C Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
03/10/2003CA2369250A1 Novel anti-viral and anti-proliferative agents derived from stat1 transcription factor
03/07/2003CA2357307A1 Raphanus with increased anthocyanin levels
03/06/2003WO2003019142A2 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque
03/06/2003WO2003018829A2 6299, a human zinc carboxypeptidase family member and uses therefor
03/06/2003WO2003018828A2 Molecular interaction sites of 16s ribosomal rna and methods of modulating the same
03/06/2003WO2003018813A2 Ashbya gossypii enzymes
03/06/2003WO2003018811A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003WO2003018810A2 Modified cry3a toxins and nucleic acid sequences coding therefor
03/06/2003WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same
03/06/2003WO2003018801A1 Cd36/fat gene promoter and diagnosis of disease associated with cd36/fat gene
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018798A2 G-protein coupled receptor and dna sequences thereof
03/06/2003WO2003018788A2 Improved nitroreductase enzymes
03/06/2003WO2003018784A1 Process for producing antigen-specific human t cells and drugs
03/06/2003WO2003018783A1 ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
03/06/2003WO2003018782A2 Differentiation of neural stem cells and therapeutic use theeof
03/06/2003WO2003018781A1 Regulation of cytotrophoblast cell differentiation and cell migration
03/06/2003WO2003018780A1 De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
03/06/2003WO2003018779A1 Isolation of cells from neural cell populations using antibodies to fa1/dlk1
03/06/2003WO2003018777A1 A universal light-switchable gene promoter system
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018767A2 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
03/06/2003WO2003018766A2 Self-processing plants and plant parts
03/06/2003WO2003018764A2 Novel human proteases and polynucleotides encoding the same
03/06/2003WO2003018760A2 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
03/06/2003WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018754A2 Neural regeneration peptide and methods for their use in treatment of brain damage
03/06/2003WO2003018752A2 An organotypic intestinal culture and methods of use thereof
03/06/2003WO2003018668A1 Cell adhesion solution
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018077A1 Method of bone regeneration
03/06/2003WO2003018058A1 Myocardial cell apoptosis inhibitors
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018041A1 Method of treating spinal injury and remedy therefor
03/06/2003WO2003018040A1 Composite graft for treatment of retinal diseases
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003004626A9 A bioprocess for the generation of cells derived from spheroid-forming cells
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002095026A8 Method of proliferating terminal differentiated cells and recombinant vector therefor
03/06/2003WO2002088337B1 Olfactory ensheathing glia produced by introducing telomerase
03/06/2003WO2002088319A3 Mini-adenoviral vector and methods of using same
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002083068A8 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
03/06/2003WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination
03/06/2003WO2002076578A9 Control of glycoforms in igg
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002064179A8 Bioartificial primarily vascularized tissue matrix, bioartificial primarily vascularized tissue, method for the production thereof and use of the same
03/06/2003WO2002064092A3 Method for evaluating therapeutic efficacy
03/06/2003WO2002062959A3 Hepatitis b virus treatment
03/06/2003WO2002060929A3 Polymer conjugates of neublastin and methods of using same
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002055719A3 Expression of foreign genes from plant virus vectors
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002026947A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/06/2003WO2002020748A2 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/06/2003WO2002015701A3 Bacillus thuringiensis crystal protein hybrids
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
03/06/2003WO2002006478A8 Extracellular matrix protein
03/06/2003WO2001098361A9 Agonist anti-trk-c monoclonal antibodies
03/06/2003WO2001098358A9 Compositions for identification and isolation of stem cells
03/06/2003WO2001098343A9 Conserved diaphanous-related formin autoregulatory domain (dad)
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001090313A9 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001072781A9 Human genes and expression products
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030046732 Methods for regulating plant GABA production
03/06/2003US20030046730 Starch branching enzyme II of potato
03/06/2003US20030046726 Encode for insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis
03/06/2003US20030046721 HSPC150-like gene disruptions, compositions and methods related thereto
03/06/2003US20030046714 Anti-neovasculature preparations for cancer
03/06/2003US20030045703 Novel forms of T cell costimulatory molecules and uses therefor
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 ... 1827